Diagnosis, Pathology & Imaging
Understanding Biphasic Mesothelioma and Its Diagnostic Challenges
Biphasic mesothelioma contains epithelioid and sarcomatoid components. How pathologists identify it and why the mix affects prognosis and treatment.
Diagnosis, Pathology & Imaging
Biphasic mesothelioma contains epithelioid and sarcomatoid components. How pathologists identify it and why the mix affects prognosis and treatment.
Treatment & Supportive Care
How chemotherapy is used in mesothelioma, the standard drug combinations, what response rates realistically look like, and how side effects are managed.
Diagnosis, Pathology & Imaging
The three main mesothelioma subtypes, how pathologists tell them apart, and why accurate subclassification changes prognosis and treatment planning.
Diagnosis, Pathology & Imaging
Understanding the complexities of diagnosing and distinguishing sarcomatoid mesothelioma from other spindle cell tumors.
Diagnosis, Pathology & Imaging
Epithelioid mesothelioma is the most common and most treatable subtype. How it is diagnosed and distinguished from adenocarcinoma and reactive change.
Treatment & Supportive Care
Immunotherapy, targeted agents, tumour treating fields, and trial options for mesothelioma beyond standard chemotherapy, and who is likely to benefit.
Diagnosis, Pathology & Imaging
The role of ancillary studies in differentiating mesothelioma from adenocarcinoma using histochemistry, immunohistochemistry, and electron microscopy.
Treatment & Supportive Care
Where radiotherapy fits into mesothelioma care, how it is used after surgery and for symptom relief, and what patients can expect during treatment.
Diagnosis, Pathology & Imaging
Rare mesothelioma variants including deciduoid, lymphohistiocytoid, and small cell forms, how they are recognised, and why they are easily misdiagnosed.
Page 1 of 2